Articles by Erin Slifka

U.S. airports had their busiest day since the Covid-19 pandemic began, but overall disruptions were less severe than during recent holidays.

The debate over medication abortions draws in the lone U.S. manufacturer of brand-name mifepristone.

Tight supplies of commodities following Russia’s war in Ukraine lead countries back to the dirtiest fossil fuel, despite commitments to tackle climate change.

Intel and Nvidia are among the semiconductor makers warning of rockier times ahead after two years of surging demand across their product lineups, pointing to a chillier consumer climate.

The excess inventory piling up at large retailers is proving a boon for liquidators and other companies that help dispose of the oversupply.

The latest film in the Despicable Me franchise posted the strongest opening weekend for an animated feature since before the pandemic.

Doctors in some countries, such as Australia and Japan, are prescribing Merck’s Covid-19 antiviral pill more frequently than Pfizer’s Paxlovid, citing a risk of drug interactions.

Three weeks since the crypto lender said it was halting withdrawals, users want answers.

Unable or unwilling to stomach higher prices, many Americans are starting to forgo some purchases and outings—even the smallest luxuries: “I kind of second guess if I really needed to get this extra pack of chips.”

At least 50 federal lawsuits in the U.S. alleging trademark or copyright infringement have named Shein or its Hong Kong-based parent company, Zoetop Business, in the past three years.